SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: santhosh mohan who wrote (3997)5/8/1998 12:36:00 PM
From: Linda Kaplan  Read Replies (2) of 7041
 
I'm not sure they'd be much different from last Q's earnings. There wouldn't have been another payment from SGP. As we recently hashed out, the next payment won't be due till after the FDA application is filed and accepting for filing by the FDA. No filing has yet occurred. The main expectation, which has been driving up the price of the stock, is that they'll get their drug approved and that it will be very successful. But there are no indications that the drug works, not to mention could rival Viagra, since even the best of the info from the tests that we have suggests it doesn't work as well and targets a much smaller population. So the stock is moving not on prior performance (which you'd be getting from current earnings reports) but hopes for future performance. Not that one can't make money out of hype: people are! But when the reality hits, one can lose a lot, too.

Linda
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext